Neuraminidase < Neutralization Tests < Neutrophil Infiltration

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000014 (2018)	Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000029 (2017)	Mizuho Suzuki [Japon] ; Masatoshi Okamatsu [Japon] ; Takahiro Hiono [Japon] ; Keita Matsuno [Japon] ; Yoshihiro Sakoda [Japon]	Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice.
000040 (2017)	Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [Indonésie]	In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.
000064 (2015)	Gerald Aichinger [Oman] ; Barbara Grohmann-Izay [Autriche] ; Maikel V W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P Noel Barrett [Autriche]	Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
000087 (2014)	Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]	The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000106 (2013)	Cyrille Dreyfus [États-Unis] ; Damian C. Ekiert ; Ian A. Wilson	Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin.
000109 (2013)	Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. Gray	Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers.
000137 (2012)	Chao Qiu [République populaire de Chine] ; Yang Huang ; Qian Wang ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing Xu	Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine.
000149 (2011)	Nobuko Ohshima [Japon] ; Yoshitaka Iba ; Ritsuko Kubota-Koketsu ; Yoshizo Asano ; Yoshinobu Okuno ; Yoshikazu Kurosawa	Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.
000159 (2011)	Danuta M. Skowronski [Canada] ; Travis S. Hottes ; Janet E. Mcelhaney ; Naveed Z. Janjua ; Suzana Sabaiduc ; Tracy Chan ; Beth Gentleman ; Dale Purych ; Jennifer Gardy ; David M. Patrick ; Robert C. Brunham ; Gaston De Serres ; Martin Petric	Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
000167 (2011)	Nicola Clementi [Italie] ; Donata De Marco ; Nicasio Mancini ; Laura Solforosi ; Guisella J. Moreno ; Larisa V. Gubareva ; Vasiliy Mishin ; Andrea Di Pietro ; Elisa Vicenzi ; Antonio G. Siccardi ; Massimo Clementi ; Roberto Burioni	A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.
000188 (2010)	Grace L. Chen [États-Unis] ; Elaine W. Lamirande ; Chin-Fen Yang ; Hong Jin ; George Kemble ; Kanta Subbarao	Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets.
000220 (2009)	Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao	A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
000225 (2008)	Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky	Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
000281 (2006)	Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. Seong	Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
000282 (2006)	J A Desheva [Russie] ; X H Lu ; A R Rekstin ; L G Rudenko ; D E Swayne ; N J Cox ; J M Katz ; A I Klimov	Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
000301 (2004)	N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. Saenger	Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
000376 (1994)	M. Tamura ; R G Webster ; F A Ennis	Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.
000379 (1994)	I N Mbawuike [États-Unis] ; S B Dillion ; S G Demuth ; C S Jones ; T R Cate ; R B Couch	Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
000387 (1993)	Y. Okuno [Japon] ; Y. Isegawa ; F. Sasao ; S. Ueda	A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.
000404 (1990)	I N Mbawuike [États-Unis] ; H R Six ; T R Cate ; R B Couch	Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Neutralization Tests" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Neutralization Tests" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neutralization Tests
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021